Methods for the detection of tuaminoheptane
Gespeichert in:
| Deutscher übersetzter Titel: | Methoden für den Nachweis von Tuaminoheptan |
|---|---|
| Autor: | Sigmund, G.; Thevis, Mario; Koch, A.; Schänzer, Wilhelm; Guddat, S. |
| Erschienen in: | Recent advances in doping analysis (16) : Proceedings of the Manfred Donike Workshop ; 26th Cologne Workshop on Dope Analysis ; 24th to 29th February 2008 |
| Veröffentlicht: | Köln: Sportverl. Strauß (Verlag), 2008, S. 301-304, Lit. |
| Format: | Literatur (SPOLIT) |
| Publikationstyp: | Sammelwerksbeitrag |
| Medienart: | Elektronische Ressource (online) Gedruckte Ressource |
| Sprache: | Englisch |
| Schlagworte: | |
| Online Zugang: | |
| Erfassungsnummer: | PU200909005085 |
| Quelle: | BISp |
Abstract
Since January 2007, the list of prohibited substances established by the World Anti-Doping Agency includes the sympathomimetic compound tuaminoheptane (2-heptylamine, 1 -methyl-hexylamine). It belongs to the class of primary amines wich sympathomimetic activity that are commonly employed in the treatment of nasal obstruction and reduced air flow or as conjunctival decongestant by local application to the mucous membranes of the eye. Tuaminoheptane is the active component, for example, of the topical intranasal drug Rhinofluimucil, which is available over-the-counter in several European countries. In this study, different methods for the detection of tuaminoheptane in urine samples using GC-MS and LC-MS-MS are described. Einleitung